Aurobindo has received the Food and Drug Administration’s permission for phenoxybenzamine hydrochloride capsules 10 mg, which is the generic of Concodia’s Dibenzyline.
Phenoxybenzamine hydrochloride capsules are indicated in the treatment of pheochromocytoma, to control episodes of hypertension and sweating.
[Read more: Aurobindo receives FDA approval for 3 generics]
Phenoxybenzamine hydrochloride capsules have a market value of approximately $7.4 million for the 12 months ending March 2023, per IQVIA.
[Read more: Aurobindo obtains FDA OK for 2 generics]